Fluorometholone

This MedLibrary.org supplementary page on Fluorometholone is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Fluorometholone
Systematic (IUPAC) name
(6S,8S,9R,10S,11S,13S,14S,17R)- 17-acetyl-9-fluoro-11,17-dihydroxy- 6,10,13-trimethyl- 6,7,8,11,12,14,15,16- octahydrocyclopenta[a] phenanthren-3-one
Identifiers
CAS number 426-13-1
ATC code C05AA06 D07AB06, D07XB04, D10AA01, S01BA07, S01CB05
PubChem 9878
DrugBank APRD00980
Chemical data
Formula C22H29FO4 
Mol. mass 376.462 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

C

Legal status
Routes  ?
Flucon as perscribed in Australia.
Flucon as perscribed in Australia.

Fluorometholone is a corticosteroid, most often used after laser-based refractive surgery. It is marketed under the brand names FML (Allergan) and Flarex (Alcon).

Fluorometholone acetate ophthalmic suspension is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye.

External links


Wikipedia content modification information:

  • This page was last modified on 13 February 2008, at 15:55.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Fluorometholone".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.